tirzepatide adverse effects Comparative safety and side of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide and #tirzepatide have improved

Our previous work concluded that this was a consequence of glucagon deficiency rather than improved insulin sensitivity or secretion, as determined by a hyperinsulinaemiceuglycaemic clamp and an IVGTT [9]

Genetic factors, baseline body weight, lifestyle habits, and adherence influence outcomes

At 12 months, there were no differences in the proportion of adults who lost at least 5% and at least 10% of their body weight between the two groups

additionally, several randomized studies have demonstrated improvements in hepatic steatosis and metabolic markers in populations with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis [28,29,30]